

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.58468294 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58468294 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.34595400 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25950056 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25950056 |
| 6 | exogenous drug catabolic process (GO:0042738) | 7.00293307 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.93244368 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.73426019 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26033671 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.01046984 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.01046984 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.01046984 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.79185318 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.78674318 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.68483868 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.67860916 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.58923471 |
| 18 | regulation of plasminogen activation (GO:0010755) | 5.57819190 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.51745417 |
| 20 | urea metabolic process (GO:0019627) | 5.51477645 |
| 21 | urea cycle (GO:0000050) | 5.51477645 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.49106875 |
| 23 | protein carboxylation (GO:0018214) | 5.49106875 |
| 24 | ethanol metabolic process (GO:0006067) | 5.43499796 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.41116803 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.40478590 |
| 27 | regulation of protein activation cascade (GO:2000257) | 5.35900170 |
| 28 | cysteine metabolic process (GO:0006534) | 5.32251012 |
| 29 | drug metabolic process (GO:0017144) | 5.24210399 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 5.18433852 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 5.17084258 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 5.14619453 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.08308086 |
| 34 | regulation of complement activation (GO:0030449) | 4.98316361 |
| 35 | bile acid metabolic process (GO:0008206) | 4.96628431 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 4.90756163 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.89856954 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.85881653 |
| 39 | phospholipid efflux (GO:0033700) | 4.81308758 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.80492281 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.80492281 |
| 42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.80492281 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.78346481 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.76371745 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.70153449 |
| 46 | negative regulation of blood coagulation (GO:0030195) | 4.70153449 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.67836737 |
| 48 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66076381 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.62520196 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.62520196 |
| 51 | oxidative demethylation (GO:0070989) | 4.61062599 |
| 52 | regulation of humoral immune response (GO:0002920) | 4.54976924 |
| 53 | phenylpropanoid metabolic process (GO:0009698) | 4.54668579 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.50985614 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.50985614 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 4.48635107 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.42782034 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.35038994 |
| 59 | negative regulation of coagulation (GO:0050819) | 4.32764582 |
| 60 | coenzyme catabolic process (GO:0009109) | 4.31098258 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.28629947 |
| 62 | cholesterol efflux (GO:0033344) | 4.28601240 |
| 63 | lysine metabolic process (GO:0006553) | 4.28459520 |
| 64 | lysine catabolic process (GO:0006554) | 4.28459520 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.27531801 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.22084536 |
| 67 | amine catabolic process (GO:0009310) | 4.22084536 |
| 68 | negative regulation of wound healing (GO:0061045) | 4.20787520 |
| 69 | positive regulation of hemostasis (GO:1900048) | 4.13554282 |
| 70 | positive regulation of blood coagulation (GO:0030194) | 4.13554282 |
| 71 | glycine metabolic process (GO:0006544) | 4.13404074 |
| 72 | cellular amino acid catabolic process (GO:0009063) | 4.13235912 |
| 73 | fibrinolysis (GO:0042730) | 4.12820960 |
| 74 | cellular ketone body metabolic process (GO:0046950) | 4.11820397 |
| 75 | negative regulation of complement activation (GO:0045916) | 4.11225554 |
| 76 | cellular glucuronidation (GO:0052695) | 4.10992534 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 4.10632343 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 4.08625921 |
| 79 | plasma lipoprotein particle assembly (GO:0034377) | 4.04459011 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.03943241 |
| 81 | glutamate metabolic process (GO:0006536) | 3.98443117 |
| 82 | negative regulation of lipase activity (GO:0060192) | 3.98277264 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.96841580 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.95955138 |
| 85 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94507471 |
| 86 | acute-phase response (GO:0006953) | 3.92846095 |
| 87 | intestinal cholesterol absorption (GO:0030299) | 3.90579973 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.90479983 |
| 89 | arginine metabolic process (GO:0006525) | 3.86454881 |
| 90 | drug catabolic process (GO:0042737) | 3.84212684 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.84129706 |
| 92 | positive regulation of coagulation (GO:0050820) | 3.82025672 |
| 93 | blood coagulation, intrinsic pathway (GO:0007597) | 3.82002487 |
| 94 | protein-lipid complex subunit organization (GO:0071825) | 3.81584942 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.80379266 |
| 96 | regulation of apoptotic cell clearance (GO:2000425) | 3.80328473 |
| 97 | complement activation (GO:0006956) | 3.79362583 |
| 98 | cofactor catabolic process (GO:0051187) | 3.78163688 |
| 99 | protein activation cascade (GO:0072376) | 3.77258227 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.74675933 |
| 101 | ethanol oxidation (GO:0006069) | 3.72379249 |
| 102 | heme transport (GO:0015886) | 3.70907699 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.70125169 |
| 104 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69379344 |
| 105 | opsonization (GO:0008228) | 3.69236297 |
| 106 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68820862 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68717657 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68717657 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.68148585 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.68148585 |
| 111 | cholesterol homeostasis (GO:0042632) | 3.67103597 |
| 112 | organic acid catabolic process (GO:0016054) | 3.63547761 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.63547761 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.62805199 |
| 115 | sterol homeostasis (GO:0055092) | 3.60886731 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.58647177 |
| 117 | S-adenosylmethionine metabolic process (GO:0046500) | 3.57997630 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.57596569 |
| 119 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.55854825 |
| 120 | ketone body metabolic process (GO:1902224) | 3.55576422 |
| 121 | acute inflammatory response (GO:0002526) | 3.55052322 |
| 122 | negative regulation of protein activation cascade (GO:2000258) | 3.55026412 |
| 123 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.54556871 |
| 124 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.54556871 |
| 125 | cytolysis (GO:0019835) | 3.53615508 |
| 126 | alkaloid metabolic process (GO:0009820) | 3.44199596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.08794624 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.93883474 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.92339083 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.29169469 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24576418 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19005489 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.63680590 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96794408 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.91519830 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01415023 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6220182 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97364172 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93538280 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86297154 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.69438410 |
| 16 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54623001 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52019355 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.51659164 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47239115 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44517220 |
| 21 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35501483 |
| 22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31823659 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23755505 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.16502623 |
| 25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05976295 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04779259 |
| 27 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03597560 |
| 28 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99341785 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99320485 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96635137 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95047672 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93381965 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92905085 |
| 34 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91628723 |
| 35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91246345 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83887996 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80995163 |
| 38 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.80346801 |
| 39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79125875 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.78448531 |
| 41 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.77288778 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76829415 |
| 43 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76325550 |
| 44 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76186139 |
| 45 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76042638 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.73836985 |
| 47 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.73764920 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73363982 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73283268 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73283268 |
| 51 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72276515 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72038560 |
| 53 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.71946790 |
| 54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71857557 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71531391 |
| 56 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70092162 |
| 57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.67826784 |
| 58 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.65868638 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.65401663 |
| 60 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64684249 |
| 61 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64537981 |
| 62 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64353845 |
| 63 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.64175021 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63470671 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.63408832 |
| 66 | AR_20517297_ChIP-Seq_VCAP_Human | 0.62640815 |
| 67 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62401833 |
| 68 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.62244978 |
| 69 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.62086429 |
| 70 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.61969380 |
| 71 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.61728026 |
| 72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.61150498 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.61117163 |
| 74 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60196128 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59126912 |
| 76 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58615626 |
| 77 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.58528359 |
| 78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58370026 |
| 79 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.57705946 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.55477360 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.54969415 |
| 82 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.53925730 |
| 83 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.53779511 |
| 84 | ERA_21632823_ChIP-Seq_H3396_Human | 0.53588862 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52658832 |
| 86 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52636722 |
| 87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52487373 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52019550 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.51491974 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.51272303 |
| 91 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.50982261 |
| 92 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.50923875 |
| 93 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.50530778 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.50502569 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.50223623 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49967858 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.49785668 |
| 98 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.49657804 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49513881 |
| 100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49348246 |
| 101 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.48628514 |
| 102 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47608046 |
| 103 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47407022 |
| 104 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47291463 |
| 105 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.47112465 |
| 106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47014625 |
| 107 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46341148 |
| 108 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46079600 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.43920564 |
| 110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43524490 |
| 111 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.42970017 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42316723 |
| 113 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41144227 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40750341 |
| 115 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.40594976 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.40022973 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39580583 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39345015 |
| 119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38885557 |
| 120 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38613259 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37884229 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.37864863 |
| 123 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.37607848 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.37606927 |
| 125 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.37219777 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37169329 |
| 127 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.36987441 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36703573 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36680644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.05929492 |
| 2 | MP0005360_urolithiasis | 7.22917186 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.42384044 |
| 4 | MP0005365_abnormal_bile_salt | 6.31420827 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.94343471 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.90276707 |
| 7 | MP0003252_abnormal_bile_duct | 3.78945087 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.43605857 |
| 9 | MP0005083_abnormal_biliary_tract | 3.30835848 |
| 10 | MP0009840_abnormal_foam_cell | 3.25776784 |
| 11 | MP0003195_calcinosis | 2.99849426 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.93500773 |
| 13 | MP0005332_abnormal_amino_acid | 2.68216829 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.55216753 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.10143684 |
| 16 | MP0000609_abnormal_liver_physiology | 2.08210283 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.07050889 |
| 18 | MP0003868_abnormal_feces_composition | 1.98003377 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.96696828 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.72760791 |
| 21 | MP0001764_abnormal_homeostasis | 1.67687246 |
| 22 | MP0002132_abnormal_respiratory_system | 1.48786382 |
| 23 | MP0009697_abnormal_copulation | 1.44483162 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43363869 |
| 25 | MP0005451_abnormal_body_composition | 1.37834222 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.32038680 |
| 27 | MP0003011_delayed_dark_adaptation | 1.25285883 |
| 28 | MP0003186_abnormal_redox_activity | 1.18858507 |
| 29 | MP0002254_reproductive_system_inflammat | 1.18775264 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.14897575 |
| 31 | MP0005647_abnormal_sex_gland | 1.10838055 |
| 32 | MP0005220_abnormal_exocrine_pancreas | 1.10807592 |
| 33 | MP0000598_abnormal_liver_morphology | 1.10161601 |
| 34 | MP0009764_decreased_sensitivity_to | 1.09820716 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.07331871 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.06066634 |
| 37 | MP0009763_increased_sensitivity_to | 1.02804451 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.01460107 |
| 39 | MP0000604_amyloidosis | 0.99902498 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 0.99776832 |
| 41 | MP0005408_hypopigmentation | 0.96744111 |
| 42 | MP0008469_abnormal_protein_level | 0.94776221 |
| 43 | MP0009642_abnormal_blood_homeostasis | 0.88951358 |
| 44 | MP0001915_intracranial_hemorrhage | 0.88480725 |
| 45 | MP0005670_abnormal_white_adipose | 0.83626307 |
| 46 | MP0003879_abnormal_hair_cell | 0.83288353 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.81856687 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.80981996 |
| 49 | MP0005376_homeostasis/metabolism_phenot | 0.74101169 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.73170419 |
| 51 | MP0003122_maternal_imprinting | 0.71974791 |
| 52 | MP0004272_abnormal_basement_membrane | 0.71754136 |
| 53 | MP0009053_abnormal_anal_canal | 0.70095212 |
| 54 | MP0001756_abnormal_urination | 0.68781908 |
| 55 | MP0002971_abnormal_brown_adipose | 0.68595786 |
| 56 | MP0005334_abnormal_fat_pad | 0.68200040 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 0.67278499 |
| 58 | MP0003690_abnormal_glial_cell | 0.67190320 |
| 59 | MP0000566_synostosis | 0.66955590 |
| 60 | MP0005535_abnormal_body_temperature | 0.65471958 |
| 61 | MP0002282_abnormal_trachea_morphology | 0.64514334 |
| 62 | MP0000639_abnormal_adrenal_gland | 0.63955392 |
| 63 | MP0009780_abnormal_chondrocyte_physiolo | 0.62969532 |
| 64 | MP0003724_increased_susceptibility_to | 0.62259790 |
| 65 | MP0002796_impaired_skin_barrier | 0.61883544 |
| 66 | MP0005464_abnormal_platelet_physiology | 0.61755240 |
| 67 | MP0003638_abnormal_response/metabolism_ | 0.61618591 |
| 68 | MP0003172_abnormal_lysosome_physiology | 0.59814971 |
| 69 | MP0005448_abnormal_energy_balance | 0.59561061 |
| 70 | MP0001661_extended_life_span | 0.57948535 |
| 71 | MP0003436_decreased_susceptibility_to | 0.56866840 |
| 72 | MP0005187_abnormal_penis_morphology | 0.56821257 |
| 73 | MP0004381_abnormal_hair_follicle | 0.56490784 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.56234092 |
| 75 | MP0004130_abnormal_muscle_cell | 0.51779549 |
| 76 | MP0002060_abnormal_skin_morphology | 0.50734347 |
| 77 | MP0002928_abnormal_bile_duct | 0.50642214 |
| 78 | MP0005266_abnormal_metabolism | 0.50508759 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.49975382 |
| 80 | MP0002089_abnormal_postnatal_growth/wei | 0.49945123 |
| 81 | MP0005023_abnormal_wound_healing | 0.49238876 |
| 82 | MP0009384_cardiac_valve_regurgitation | 0.47477847 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.47399891 |
| 84 | MP0000579_abnormal_nail_morphology | 0.46378575 |
| 85 | MP0005395_other_phenotype | 0.45896436 |
| 86 | MP0003953_abnormal_hormone_level | 0.45164755 |
| 87 | MP0008872_abnormal_physiological_respon | 0.45094462 |
| 88 | MP0009785_altered_susceptibility_to | 0.44939113 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.44050601 |
| 90 | MP0003329_amyloid_beta_deposits | 0.43284915 |
| 91 | MP0001944_abnormal_pancreas_morphology | 0.42276862 |
| 92 | MP0008873_increased_physiological_sensi | 0.42177477 |
| 93 | MP0009115_abnormal_fat_cell | 0.41717394 |
| 94 | MP0001243_abnormal_dermal_layer | 0.41414390 |
| 95 | MP0008874_decreased_physiological_sensi | 0.40125797 |
| 96 | MP0003075_altered_response_to | 0.38420802 |
| 97 | MP0002822_catalepsy | 0.37950052 |
| 98 | MP0002295_abnormal_pulmonary_circulatio | 0.37471461 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.37230929 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.37222968 |
| 101 | MP0010386_abnormal_urinary_bladder | 0.37134204 |
| 102 | MP0002837_dystrophic_cardiac_calcinosis | 0.36875475 |
| 103 | MP0002249_abnormal_larynx_morphology | 0.36039864 |
| 104 | MP0005166_decreased_susceptibility_to | 0.36000782 |
| 105 | MP0005409_darkened_coat_color | 0.35431353 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.35101051 |
| 107 | MP0003718_maternal_effect | 0.34844041 |
| 108 | MP0006082_CNS_inflammation | 0.34747366 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.33455695 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.33057128 |
| 111 | MP0002168_other_aberrant_phenotype | 0.32360825 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.32020534 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.31816353 |
| 114 | MP0000249_abnormal_blood_vessel | 0.31575743 |
| 115 | MP0009379_abnormal_foot_pigmentation | 0.31445044 |
| 116 | MP0004883_abnormal_blood_vessel | 0.31309344 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.30982105 |
| 118 | MP0002090_abnormal_vision | 0.30921005 |
| 119 | MP0001853_heart_inflammation | 0.29483214 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.29230830 |
| 121 | MP0001881_abnormal_mammary_gland | 0.29213262 |
| 122 | MP0005164_abnormal_response_to | 0.29115492 |
| 123 | MP0005410_abnormal_fertilization | 0.26702494 |
| 124 | MP0002970_abnormal_white_adipose | 0.26244979 |
| 125 | MP0000920_abnormal_myelination | 0.24903327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.54325161 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.21175949 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.16782182 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.70342700 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.68459720 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.14138202 |
| 7 | Xanthomatosis (HP:0000991) | 6.10950631 |
| 8 | Complement deficiency (HP:0004431) | 5.70435420 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.48020181 |
| 10 | Joint hemorrhage (HP:0005261) | 4.88360646 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.82638486 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.67885262 |
| 13 | Hyperammonemia (HP:0001987) | 4.43605667 |
| 14 | Epidermoid cyst (HP:0200040) | 4.30091072 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.29645758 |
| 16 | Ketosis (HP:0001946) | 4.29301412 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.27933991 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26805289 |
| 19 | Fat malabsorption (HP:0002630) | 4.25192219 |
| 20 | Abnormality of complement system (HP:0005339) | 4.20566364 |
| 21 | Hyperglycinemia (HP:0002154) | 4.18255619 |
| 22 | Hypoalphalipoproteinemia (HP:0003233) | 4.17510599 |
| 23 | Hypoglycemic coma (HP:0001325) | 4.11293966 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 4.10146861 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09041911 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.99715425 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.82465274 |
| 28 | Hyperglycinuria (HP:0003108) | 3.74080500 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.74061670 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.66836272 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.66836272 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.51622177 |
| 33 | Steatorrhea (HP:0002570) | 3.31076313 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30281940 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.26811556 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26143898 |
| 37 | Spontaneous abortion (HP:0005268) | 3.24741695 |
| 38 | Ketoacidosis (HP:0001993) | 3.22530054 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 3.15087623 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02470735 |
| 41 | Myocardial infarction (HP:0001658) | 3.01268764 |
| 42 | Glomerulonephritis (HP:0000099) | 3.01130876 |
| 43 | Delayed CNS myelination (HP:0002188) | 2.96318695 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.90642239 |
| 45 | Hypoglycemic seizures (HP:0002173) | 2.85246918 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.79498248 |
| 47 | Purpura (HP:0000979) | 2.74004221 |
| 48 | Skin nodule (HP:0200036) | 2.69324275 |
| 49 | Metabolic acidosis (HP:0001942) | 2.67362266 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.66675268 |
| 51 | Vascular calcification (HP:0004934) | 2.65893169 |
| 52 | Amyloidosis (HP:0011034) | 2.65519210 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.63666904 |
| 54 | Lethargy (HP:0001254) | 2.55137991 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50935211 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.50935211 |
| 57 | Late onset (HP:0003584) | 2.48272823 |
| 58 | Gout (HP:0001997) | 2.47328144 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46136160 |
| 60 | Osteomalacia (HP:0002749) | 2.45371609 |
| 61 | Mitral stenosis (HP:0001718) | 2.43870254 |
| 62 | Gingival bleeding (HP:0000225) | 2.41504232 |
| 63 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.40082212 |
| 64 | Cerebral edema (HP:0002181) | 2.39898413 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.37943864 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.35856547 |
| 67 | Irritability (HP:0000737) | 2.34926117 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.29079979 |
| 69 | Menorrhagia (HP:0000132) | 2.27024591 |
| 70 | Spastic diplegia (HP:0001264) | 2.25580577 |
| 71 | Pancreatitis (HP:0001733) | 2.23602637 |
| 72 | Neonatal onset (HP:0003623) | 2.23589722 |
| 73 | Acanthocytosis (HP:0001927) | 2.21065795 |
| 74 | Pulmonary embolism (HP:0002204) | 2.16991473 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.16303214 |
| 76 | Cholelithiasis (HP:0001081) | 2.15234797 |
| 77 | Malnutrition (HP:0004395) | 2.12593383 |
| 78 | Hyperglycemia (HP:0003074) | 2.12483312 |
| 79 | Thrombophlebitis (HP:0004418) | 2.11624856 |
| 80 | Esophageal varix (HP:0002040) | 2.10546332 |
| 81 | Arthropathy (HP:0003040) | 2.10115579 |
| 82 | Fair hair (HP:0002286) | 2.09714438 |
| 83 | Enlarged kidneys (HP:0000105) | 2.08851202 |
| 84 | Opisthotonus (HP:0002179) | 2.08823168 |
| 85 | Brushfield spots (HP:0001088) | 2.08141844 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.07446765 |
| 87 | Glycosuria (HP:0003076) | 2.07446765 |
| 88 | Nephritis (HP:0000123) | 2.05678449 |
| 89 | Vomiting (HP:0002013) | 2.04377697 |
| 90 | Symptomatic seizures (HP:0011145) | 2.02886655 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.02268992 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.00974934 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 1.99366849 |
| 94 | Abnormality of the Achilles tendon (HP:0005109) | 1.96882459 |
| 95 | Hyperphosphaturia (HP:0003109) | 1.92906493 |
| 96 | Rickets (HP:0002748) | 1.92381381 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 1.89970801 |
| 98 | Cholecystitis (HP:0001082) | 1.89970801 |
| 99 | Hypophosphatemic rickets (HP:0004912) | 1.89779775 |
| 100 | Bifid scrotum (HP:0000048) | 1.87663157 |
| 101 | Hemorrhage of the eye (HP:0011885) | 1.86328705 |
| 102 | Abnormality of the gallbladder (HP:0005264) | 1.85119590 |
| 103 | Alkalosis (HP:0001948) | 1.84543249 |
| 104 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81882600 |
| 105 | Renal cortical cysts (HP:0000803) | 1.80854015 |
| 106 | Joint swelling (HP:0001386) | 1.79826502 |
| 107 | Abnormality of vitamin metabolism (HP:0100508) | 1.78287654 |
| 108 | Poikilocytosis (HP:0004447) | 1.77960647 |
| 109 | Elevated hepatic transaminases (HP:0002910) | 1.77874204 |
| 110 | Retinal atrophy (HP:0001105) | 1.76489017 |
| 111 | Neonatal hypoglycemia (HP:0001998) | 1.76319087 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 1.75885838 |
| 113 | Hydroxyprolinuria (HP:0003080) | 1.75099360 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 1.75099360 |
| 115 | Increased serum ferritin (HP:0003281) | 1.72649380 |
| 116 | Abnormal tarsal ossification (HP:0008369) | 1.72508698 |
| 117 | Epistaxis (HP:0000421) | 1.67480261 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.66148628 |
| 119 | Increased serum pyruvate (HP:0003542) | 1.64855925 |
| 120 | Gangrene (HP:0100758) | 1.61925817 |
| 121 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.60696081 |
| 122 | Proximal tubulopathy (HP:0000114) | 1.59972246 |
| 123 | Potter facies (HP:0002009) | 1.58657766 |
| 124 | Facial shape deformation (HP:0011334) | 1.58657766 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 1.58007356 |
| 126 | Abnormal delivery (HP:0001787) | 1.57573288 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.57183463 |
| 128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.57183463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.73672407 |
| 2 | ERN1 | 4.87486296 |
| 3 | FGFR4 | 4.21705477 |
| 4 | SIK1 | 3.80553540 |
| 5 | INSRR | 3.63244936 |
| 6 | TAOK3 | 3.41211376 |
| 7 | MST1R | 2.53469436 |
| 8 | ERBB4 | 2.47356506 |
| 9 | PIK3CG | 2.31109849 |
| 10 | MAPK15 | 2.21345711 |
| 11 | PDK2 | 2.17775645 |
| 12 | MYLK | 2.13873904 |
| 13 | FLT3 | 1.85638724 |
| 14 | FRK | 1.84328162 |
| 15 | TYK2 | 1.79438940 |
| 16 | PKN2 | 1.75133215 |
| 17 | MAP2K4 | 1.74931828 |
| 18 | MAPK11 | 1.67980851 |
| 19 | TRIB3 | 1.58137732 |
| 20 | AKT3 | 1.55117131 |
| 21 | ICK | 1.53370445 |
| 22 | WNK4 | 1.53042954 |
| 23 | PTK6 | 1.52912868 |
| 24 | DAPK2 | 1.49277751 |
| 25 | LATS1 | 1.44297082 |
| 26 | MAP3K3 | 1.43981379 |
| 27 | NEK9 | 1.42237962 |
| 28 | IRAK3 | 1.32894758 |
| 29 | JAK2 | 1.25726266 |
| 30 | TGFBR2 | 1.17620876 |
| 31 | ABL2 | 1.17377191 |
| 32 | EPHA2 | 1.16628661 |
| 33 | TBK1 | 1.15910836 |
| 34 | EPHA3 | 1.15085552 |
| 35 | FGFR2 | 1.14901082 |
| 36 | MAP3K14 | 1.12519962 |
| 37 | PRKAA2 | 1.02175489 |
| 38 | JAK1 | 1.01899473 |
| 39 | ARAF | 1.00126818 |
| 40 | FGFR1 | 0.99750715 |
| 41 | MET | 0.99658025 |
| 42 | SGK494 | 0.99247670 |
| 43 | SGK223 | 0.99247670 |
| 44 | KDR | 0.95454205 |
| 45 | EPHB1 | 0.94035383 |
| 46 | NTRK3 | 0.93088154 |
| 47 | CDC42BPA | 0.89696716 |
| 48 | ERBB2 | 0.89491524 |
| 49 | MAP2K3 | 0.88704939 |
| 50 | MAP3K2 | 0.88020695 |
| 51 | ACVR1B | 0.85046930 |
| 52 | DYRK1B | 0.85033828 |
| 53 | STK38L | 0.83988277 |
| 54 | MAPK4 | 0.82862055 |
| 55 | MAPK12 | 0.81350208 |
| 56 | PRKG2 | 0.81111573 |
| 57 | EEF2K | 0.80120658 |
| 58 | PRKCZ | 0.79687071 |
| 59 | MAP2K2 | 0.79488709 |
| 60 | MAP3K12 | 0.79005695 |
| 61 | MAP3K7 | 0.76813350 |
| 62 | DDR2 | 0.76265511 |
| 63 | IKBKE | 0.75746223 |
| 64 | MAP2K6 | 0.74941327 |
| 65 | CSK | 0.73179081 |
| 66 | PRKG1 | 0.71015113 |
| 67 | PRKACG | 0.69869393 |
| 68 | PDGFRA | 0.68982121 |
| 69 | PINK1 | 0.67760561 |
| 70 | TIE1 | 0.67726147 |
| 71 | CDK6 | 0.67719233 |
| 72 | GSK3A | 0.67035597 |
| 73 | MARK3 | 0.66439115 |
| 74 | EIF2AK3 | 0.66019548 |
| 75 | MUSK | 0.64930527 |
| 76 | GRK1 | 0.63052124 |
| 77 | MAPK7 | 0.62741260 |
| 78 | MAP2K1 | 0.62494519 |
| 79 | IRAK1 | 0.62134561 |
| 80 | STK38 | 0.60627282 |
| 81 | MAP3K10 | 0.59923595 |
| 82 | CAMK2G | 0.59764107 |
| 83 | GRK6 | 0.59231597 |
| 84 | BRSK2 | 0.58037149 |
| 85 | PTK2 | 0.57751859 |
| 86 | NEK2 | 0.56914125 |
| 87 | FGFR3 | 0.55086579 |
| 88 | IGF1R | 0.54769539 |
| 89 | AKT2 | 0.52263156 |
| 90 | PRKAA1 | 0.51949550 |
| 91 | IRAK2 | 0.51235772 |
| 92 | CAMK1D | 0.49934209 |
| 93 | PIK3CA | 0.49892851 |
| 94 | MAP3K11 | 0.49501034 |
| 95 | TNK2 | 0.48075946 |
| 96 | RIPK1 | 0.47776970 |
| 97 | RPS6KB1 | 0.47705812 |
| 98 | CSF1R | 0.46010001 |
| 99 | PDPK1 | 0.45067100 |
| 100 | CSNK1D | 0.44780947 |
| 101 | SGK1 | 0.41802223 |
| 102 | LMTK2 | 0.41712161 |
| 103 | GRK7 | 0.41613913 |
| 104 | MAP3K1 | 0.40793988 |
| 105 | CAMKK2 | 0.40691112 |
| 106 | OBSCN | 0.39981613 |
| 107 | EPHB2 | 0.38424525 |
| 108 | MAPKAPK3 | 0.37571103 |
| 109 | PRKCQ | 0.37223851 |
| 110 | SGK3 | 0.37088913 |
| 111 | PRKACB | 0.36452204 |
| 112 | ZAP70 | 0.35729761 |
| 113 | SRC | 0.35388112 |
| 114 | RET | 0.35238548 |
| 115 | STK16 | 0.35044882 |
| 116 | ITK | 0.35037262 |
| 117 | PRKCE | 0.34903157 |
| 118 | TRPM7 | 0.34848415 |
| 119 | CSNK2A1 | 0.34557861 |
| 120 | CSNK1A1 | 0.33721550 |
| 121 | MAP3K9 | 0.33319435 |
| 122 | CSNK1E | 0.33290951 |
| 123 | LATS2 | 0.33097690 |
| 124 | EGFR | 0.32986093 |
| 125 | FER | 0.31365967 |
| 126 | SGK2 | 0.29097119 |
| 127 | CAMK4 | 0.28434333 |
| 128 | MAP3K5 | 0.27823869 |
| 129 | PKN1 | 0.27433833 |
| 130 | MAPK3 | 0.27005042 |
| 131 | PRKCG | 0.26971951 |
| 132 | PRKCA | 0.26700275 |
| 133 | CSNK1G1 | 0.26168270 |
| 134 | IKBKB | 0.25748607 |
| 135 | TAOK2 | 0.25280313 |
| 136 | MTOR | 0.25112339 |
| 137 | PDK1 | 0.23500868 |
| 138 | PAK3 | 0.23454791 |
| 139 | ABL1 | 0.22974179 |
| 140 | CHUK | 0.21895120 |
| 141 | PRKACA | 0.18576743 |
| 142 | BLK | 0.18378681 |
| 143 | NLK | 0.18179852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.57452868 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35466306 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32289737 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29062518 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01616614 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.91563598 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67895849 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53589453 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.48101646 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46505781 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.39601304 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35998392 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.29082075 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26420233 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.07214670 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.05920889 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.04085045 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01909053 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95339502 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95095444 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91076441 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82173351 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.81292150 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76397886 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76395979 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68450588 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68182850 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68020238 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66399605 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64200086 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63922487 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63236042 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60605081 |
| 34 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.50224783 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48922856 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47471680 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.44177604 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43443029 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40774684 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39440438 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31257928 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31046979 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24239214 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.24083135 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.23357365 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21157887 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20671345 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16222525 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13571183 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07979009 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99188350 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.96755547 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95256185 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93509320 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90602853 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89278033 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76896649 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74865866 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.73093280 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70095398 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68194947 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64661808 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62043486 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59522804 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51706276 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48362605 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46891311 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.42139742 |
| 69 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35598151 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34811380 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34705146 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31849199 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26666563 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.26281416 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24113610 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.23764585 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19003697 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15193532 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09872899 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.09320721 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08866992 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08430680 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07033354 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.01990267 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.01169755 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.01102784 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1675183 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1671148 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1618459 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1517510 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1511808 |
| 92 | Pertussis_Homo sapiens_hsa05133 | -0.1482549 |
| 93 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1435587 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | -0.1374871 |
| 95 | Lysosome_Homo sapiens_hsa04142 | -0.1369307 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1346187 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1264973 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0999709 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0945555 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0934684 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0877047 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0785794 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0773848 |
| 104 | Protein export_Homo sapiens_hsa03060 | -0.0441016 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0379697 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0262862 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0200653 |
| 108 | Amoebiasis_Homo sapiens_hsa05146 | -0.0157755 |

